Fusion Bioline Vascular Graft— 510(k) K252445

Substantially Equivalent

Maquet Cardiovascular, LLC

FDA 510(k) clearance K252445 for Fusion Bioline Vascular Graft, Substantially Equivalent on 2026-04-27. Applicant: Maquet Cardiovascular, LLC. Device class: 2.

Summary

Maquet Cardiovascular's Fusion Bioline Vascular Graft is filed under product code DSY (Prosthesis, Vascular Graft, Of 6mm And Greater Diameter).

Class II, 21 CFR 870.3450. Cardiovascular is both the classification panel and the review panel. It came in as a Traditional 510(k).

Maquet Cardiovascular filed from Wayne, New Jersey. The record shows 266 calendar days from receipt to decision (August 4, 2025 to April 27, 2026).

Clearance details

Applicant
Maquet Cardiovascular, LLC
Product code
Product code DSY
Device class
Class 2
Regulation
21 CFR 870.3450
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Wayne, NJ, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DSY

view all

More clearances from Maquet Cardiovascular, LLC

view all

Adverse events under product code DSY

product code DSY
Death
29
Injury
694
Total
723

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.